- Report
- February 2025
- 175 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- August 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- August 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- July 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- July 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- May 2025
- 100 Pages
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- May 2025
- 100 Pages
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- March 2025
- 120 Pages
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- August 2025
- 378 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 365 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 279 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 224 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 488 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 235 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 374 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 384 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 419 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 578 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 577 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 172 Pages
Global
From €5205EUR$5,850USD£4,494GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more